Provided by Tiger Trade Technology Pte. Ltd.

PharmaCyte Biotech, Inc.

0.4881
-0.0128-2.56%
Volume:55.15K
Turnover:27.26K
Market Cap:5.24M
PE:-0.18
High:0.5090
Open:0.4900
Low:0.4801
Close:0.5009
52wk High:1.51
52wk Low:0.4800
Shares:10.74M
Float Shares:10.07M
Volume Ratio:0.71
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7700
EPS(LYR):-2.7700
ROE:-44.72%
ROA:-6.51%
PB:0.16
PE(LYR):-0.18

Loading ...

May 31, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 23, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 18, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 25, 2023

Major Issues Report

Form 8-K - Current report
Nov 23, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Nov 16, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 28, 2023

Correspondence

Form CORRESP - Correspondence
Sep 18, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 05, 2023

Correspondence

Form CORRESP - Correspondence
Aug 04, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2023

Major Issues Report

Form 8-K - Current report
Jun 17, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 05, 2023

Correspondence

Form CORRESP - Correspondence